ANTIPHOSPHOLIPID antibodies have been associated with a variety of clinical phenomena,
including arterial and venous thrombosis, thrombocytopenia, and obstetric complications …

Anti‐phospholipid antibodies (aPL) are associated with an increased risk of thrombosis and
recurrent fetal loss. Antibodies to prothrombin (aPT) have been associated with the anti …

Antiphospholipid antibodies are associated with arterial and venous thrombosis, recurrent
pregnancy loss, and thrombocytopenia. Although the antibodies have not been conclusively …

Dear Editor, Antiphospholipid antibody syndrome (APS) is characterized by arterial and
venous thrombosis, recurrent fetal loss, and by thrombocytopenia which is presumably …

Antiphospholipid antibodies are a wide and heterogeneous group of immunoglobulins that
include, among others, lupus anticoagulants and anticardiolipin antibodies. Their presence …

Antiphospholipid syndrome (APS) is an autoimmune disease characterized clinically by the
occurrence of venous or arterial thrombosis, and/or pregnancy morbidity. The detection of …

Antiphospholipid antibodies, that is, lupus anticoagulants and anticardiolipin antibodies, are
associated with thrombosis and obstetric complications in the antiphospholipid syndrome …

Antiphospholipid antibodies are increasingly being identified as a cause of both arterial and
venous thrombosis as well as fetal wastage syndrome via placental vascular thrombosis …

Background The antiphospholipid-antibody syndrome is a thrombophilic disorder in which
venous or arterial thrombosis, or both, may occur in patients with antiphospholipid …

The antiphospholipid syndrome (APS) was reported in the early 1980s as the association of
thrombosis, recurrent pregnancy loss in the presence of anticardiolipin antibodies (aCL) …